TrialCancer medicine2019

Effects of serum from breast cancer surgery patients receiving perioperative dexmedetomidine on breast cancer cell malignancy: A prospective randomized controlled trial.

Yan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.